FDCDDQ
VERA icon

Federation des caisses Desjardins du Quebec’s Vera Therapeutics VERA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80
Closed -$4.05K – 3089
2025
Q4 		$4.05K Buy
80
+60
+300% +$2.13K ﹤0.01% 2494
2025
Q3 		$581 Hold
20
– – ﹤0.01% 2717
2025
Q2 		$471 Hold
20
– – ﹤0.01% 2582
2025
Q1 		$480 Hold
20
– – ﹤0.01% 2493
2024
Q4 		$846 Hold
20
– – ﹤0.01% 2338
2024
Q3 		$884 Buy
+20
New +$759 ﹤0.01% 2335

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's VERA Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 80 shares — an estimated $4.05K sold.

Federation des caisses Desjardins du Quebec first reported a position in VERA in Q3 2024 and held it in 6 quarters. The position peaked at $4.05K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Federation des caisses Desjardins du Quebec reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 80 Vera Therapeutics shares in Q1 2026, an estimated $4.05K.
  • Federation des caisses Desjardins du Quebec first reported a position in Vera Therapeutics in Q3 2024 and held it in 6 quarters.
  • Federation des caisses Desjardins du Quebec's Vera Therapeutics position peaked at $4.05K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.